Cellebrite DI Ltd.
CLBT
$13.18
$0.010.08%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 128.82M | 113.28M | 107.55M | 109.05M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 128.82M | 113.28M | 107.55M | 109.05M | |
| Cost of Revenue | 19.69M | 17.68M | 17.49M | 17.63M | |
| Gross Profit | 109.13M | 95.60M | 90.06M | 91.42M | |
| SG&A Expenses | 58.46M | 50.47M | 50.51M | 50.10M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 108.02M | 96.76M | 95.28M | 93.32M | |
| Operating Income | 20.81M | 16.52M | 12.27M | 15.73M | |
| Income Before Tax | 26.27M | 20.79M | 19.33M | 19.90M | |
| Income Tax Expenses | 5.01M | 1.32M | 1.93M | 628.00K | |
| Earnings from Continuing Operations | 21.26M | 19.48M | 17.40M | 19.27M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 21.26M | 19.48M | 17.40M | 19.27M | |
| EBIT | 20.81M | 16.52M | 12.27M | 15.73M | |
| EBITDA | 24.75M | 19.11M | 14.90M | 18.45M | |
| EPS Basic | 0.08 | 0.08 | 0.07 | 0.08 | |
| Normalized Basic EPS | 0.07 | 0.06 | -- | 0.05 | |
| EPS Diluted | 0.08 | 0.08 | 0.07 | 0.08 | |
| Normalized Diluted EPS | 0.07 | 0.06 | -- | 0.05 | |
| Average Basic Shares Outstanding | 245.28M | 240.36M | 237.25M | 233.25M | |
| Average Diluted Shares Outstanding | 251.50M | 248.98M | 249.30M | 247.35M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |